91 related articles for article (PubMed ID: 9419970)
1. Repression of hepatitis B virus (HBV) transgene and HBV-induced liver injury by low protein diet.
Hu JF; Cheng Z; Chisari FV; Vu TH; Hoffman AR; Campbell TC
Oncogene; 1997 Dec; 15(23):2795-801. PubMed ID: 9419970
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of hepatocellular carcinoma development in hepatitis B virus transfected mice by low dietary casein.
Cheng Z; Hu J; King J; Jay G; Campbell TC
Hepatology; 1997 Nov; 26(5):1351-4. PubMed ID: 9362383
[TBL] [Abstract][Full Text] [Related]
3. Inducing oral immune regulation of hepatitis B virus envelope proteins suppresses the growth of hepatocellular carcinoma in mice.
Gotsman I; Alper R; Klein A; Rabbani E; Engelhardt D; Ilan Y
Cancer; 2002 Jan; 94(2):406-14. PubMed ID: 11900226
[TBL] [Abstract][Full Text] [Related]
4. Chronic ethanol consumption stimulates hepatitis B virus gene expression and replication in transgenic mice.
Larkin J; Clayton MM; Liu J; Feitelson MA
Hepatology; 2001 Oct; 34(4 Pt 1):792-7. PubMed ID: 11584377
[TBL] [Abstract][Full Text] [Related]
5. Stable transmission and expression of the hepatitis B virus total genome in hybrid transgenic mice until F10 generation.
Bagis H; Arat S; Mercan HO; Aktoprakligil D; Caner M; Turanli ET; Baysal K; Turgut G; Sekmen S; Cirakoglu B
J Exp Zool A Comp Exp Biol; 2006 May; 305(5):420-7. PubMed ID: 16489557
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B injury, male gender, aflatoxin, and p53 expression each contribute to hepatocarcinogenesis in transgenic mice.
Ghebranious N; Sell S
Hepatology; 1998 Feb; 27(2):383-91. PubMed ID: 9462635
[TBL] [Abstract][Full Text] [Related]
7. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
Jakubczak JL; Chisari FV; Merlino G
Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
[TBL] [Abstract][Full Text] [Related]
8. Cell type-specific mechanisms regulate hepatitis B virus transgene expression in liver and other organs.
Aragona E; Burk RD; Ott M; Shafritz DA; Gupta S
J Pathol; 1996 Dec; 180(4):441-9. PubMed ID: 9014867
[TBL] [Abstract][Full Text] [Related]
9. Specific anti-viral effects of RNA interference on replication and expression of hepatitis B virus in mice.
Wu Y; Huang AL; Tang N; Zhang BQ; Lu NF
Chin Med J (Engl); 2005 Aug; 118(16):1351-6. PubMed ID: 16157029
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of low-level hepatitis B viremia in patients with HBV surface antigen-negative hepatocellular carcinoma with and without hepatitis C virus infection in Japan: analysis by COBAS TaqMan real-time PCR.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A
Intervirology; 2007; 50(4):241-4. PubMed ID: 17446712
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profile of transgenic mouse kidney reveals pathogenesis of hepatitis B virus associated nephropathy.
Ren J; Wang L; Chen Z; Ma ZM; Zhu HG; Yang DL; Li XY; Wang BI; Fei J; Wang ZG; Wen YM
J Med Virol; 2006 May; 78(5):551-60. PubMed ID: 16555286
[TBL] [Abstract][Full Text] [Related]
12. Transgenic mice replicating hepatitis B virus but lacking expression of the major HBsAg.
Halverscheid L; Mannes NK; Weth R; Kleinschmidt M; Schultz U; Reifenberg K; Schirmbeck R; Nassal M; Blum HE; Reimann J; Geissler M
J Med Virol; 2008 Apr; 80(4):583-90. PubMed ID: 18297704
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus sensitizes hepatocytes to complement-dependent cytotoxicity through downregulating CD59.
Qu Z; Liang X; Liu Y; Du J; Liu S; Sun W
Mol Immunol; 2009 Dec; 47(2-3):283-9. PubMed ID: 19804910
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of hepatitis B virus in mice by RNA interference.
McCaffrey AP; Nakai H; Pandey K; Huang Z; Salazar FH; Xu H; Wieland SF; Marion PL; Kay MA
Nat Biotechnol; 2003 Jun; 21(6):639-44. PubMed ID: 12740585
[TBL] [Abstract][Full Text] [Related]
15. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
16. Direct cytopathic effects of particular hepatitis B virus genotypes in severe combined immunodeficiency transgenic with urokinase-type plasminogen activator mouse with human hepatocytes.
Sugiyama M; Tanaka Y; Kurbanov F; Maruyama I; Shimada T; Takahashi S; Shirai T; Hino K; Sakaida I; Mizokami M
Gastroenterology; 2009 Feb; 136(2):652-62.e3. PubMed ID: 19041311
[TBL] [Abstract][Full Text] [Related]
17. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
18. Titration of hepatitis B virus infectivity in the sera of pre-acute and late acute phases of HBV infection: transmission experiments to chimeric mice with human liver repopulated hepatocytes.
Tabuchi A; Tanaka J; Katayama K; Mizui M; Matsukura H; Yugi H; Shimada T; Miyakawa Y; Yoshizawa H
J Med Virol; 2008 Dec; 80(12):2064-8. PubMed ID: 19040280
[TBL] [Abstract][Full Text] [Related]
19. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens.
Sugiyama M; Tanaka Y; Kato T; Orito E; Ito K; Acharya SK; Gish RG; Kramvis A; Shimada T; Izumi N; Kaito M; Miyakawa Y; Mizokami M
Hepatology; 2006 Oct; 44(4):915-24. PubMed ID: 17006908
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B virus DNA in liver tissue and risk for hepatocarcinogenesis in patients with hepatitis C virus-related chronic liver disease. A prospective study.
Obika M; Shinji T; Fujioka S; Terada R; Ryuko H; Lwin AA; Shiraha H; Koide N
Intervirology; 2008; 51(1):59-68. PubMed ID: 18349544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
